However, the inhibition of KIF11 obtained with two small synthetic molecules different from K858 showed pronounced antitumor activity in xenograft mice with breast cancer without determining any signs of peripheral neuropathy, as is common with other microtubule-targeting anticancer compounds [36]. Here, KIF11 is linked to breast cancer.